CERES Service
Medical Writing
We ensure MDR compliance and keep up to date with regulatory changes.
Home / Medical Writing
Reliability from R&D
to Market Surveillance
Our medical writing team is composed of scientists, engineers and physicians who specialise in the preparation of essential documents required for clinical investigation applications to ethics committees and competent authorities.
Among many others, these documents include comprehensive literature research leading to a state-of-the-art (SOTA) document, a clinical evaluation plan (CEP) and clinical evaluation report (CER). In the case of a clinical investigation planned and executed for your medical device, the services provided by medical writing extend to the clinical investigation plan (CIP), the patient informed consent
(PIC), the investigator´s brochure (IB), and the clinical investigation report (CIR).
In addition, the case report form (CRF) is compiled by our experts. Moreover, our medical writers compile all documents for Orphan Medical Devices as well as Legacy Devices and handle Well-Established Technologies (WET).
All medical writing documents follow the requirements of the 2017/745 Medical Device Regulation (MDR) Articles 61-82. With every change of regulation, we have our finger on the pulse of time.
Services included
Medical Writing
Various databases can also be used to identify complaints as well as recalls that are related to the product, device or application in question.
The research allows evaluations to be carried out, the market situation and changes to be monitored and PMCF measures to be implemented.
intended clinical investigation. The CIP is written by our experts with extensive know-how in the design and execution of clinical trials. The trial planning is carried out according to the purpose and objective of the clinical investigation, from the feasibility study to approval and market surveillance. The CIP details how the product characteristics are to be validated, confirmed or identified in terms of safety, performance and risk-benefit assessment.
the manufacturer must establish a performance evaluation plan (PEP).
The PEP defines the performance evaluation process and outlines key
parameters, taking into account the intended purpose and use of the IVD, the specification of the analyte to be determined, the target patient groups, clear indications, possible contraindications, and limitations. Additionally, the PEP should detail the intended methods and statistical tools used to evaluate the analytical and, if applicable, clinical performance of the IVD.
Full-Service CRO
The CERES Advantage
-
Tailored Services
You choose with the help of our consulting services – is a tailored modular service ideal for you? Or do you prefer to book a package, intro or large?
It is your decision – just ask us.
-
Transparent Costs
Whatever you decide you need – our modular services or the carefree package – you will receive a detailed offer with transparent and comprehensible costs. No hidden fees. -
Plan Your ROI
Our expertise helps you to reach your aims sooner, more efficiently and more economically: to market introduction and a projectable and secure ROI. -
The Best Team for Your Success
Our colleagues are experts in medicine, the sciences, biostatistics and engineering. This interdisciplinary team takes you safely to your goal. -
Experience and Know-How
We combine decades-long experience with focused know-how – we are your partner at eye level! You can rely on us – with us, you cannot go wrong.
We look forward to meeting you!
-
A Very Strong Network
For over 20 years, we have been working in this field – we are familiar with everyone involved! Rely on our strong network and benefit from a well-established CRO.
Medical Writing Request
With Care and Expertise –
for Your Project
now want to conquer the market? We support you in the
most important core processes!
We make sure that all interfaces are defined and
considered. With us, you will always be
up to date.